🇺🇸 Estradiol + Progesterone in United States

41 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 41

Most-reported reactions

1. Fatigue — 6 reports (14.63%)
2. Off Label Use — 6 reports (14.63%)
3. Nausea — 5 reports (12.2%)
4. Drug Ineffective — 4 reports (9.76%)
5. Pain — 4 reports (9.76%)
6. Weight Decreased — 4 reports (9.76%)
7. Abdominal Discomfort — 3 reports (7.32%)
8. Arthralgia — 3 reports (7.32%)
9. Bruxism — 3 reports (7.32%)
10. Condition Aggravated — 3 reports (7.32%)

Source database →

Frequently asked questions

Is Estradiol + Progesterone approved in United States?

Estradiol + Progesterone does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Estradiol + Progesterone in United States?

Productos Científicos S. A. de C. V. is the originator. The local marketing authorisation holder may differ — check the official source linked above.